Study of phosphatidylserine-dependent anti-prothrombin antibody in cerebral infarction

Internal Medicine

Volumn 48, Issue 16, 2009, Pages 1351-1355

  Okuma, Hirohisa ^a   Kitagawa, Yasuhisa ^b   Ishikawa, Tatsuya ^c   Takagi, Shigeharu ^c  

^a TOKAI UNIVERSITY TOKYO HOSPITAL   (Japan)

^b TOKAI UNIVERSITY HACHIOJI HOSPITAL   (Japan)

^c TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Cerebral infarction; Phosphatidylserine dependent anti prothrombin antibody

Indexed keywords

CARDIOLIPIN ANTIBODY; IMMUNOGLOBULIN G BETA 2 GLYCOPROTEIN I DEPENDENT CARDIOLIPIN ANTIBODY; IMMUNOGLOBULIN G PHOSPHATIDYLSERINE DEPENDENT PROTHROMBIN ANTIBODY; LUPUS ANTICOAGULANT; PROTHROMBIN ANTIBODY; UNCLASSIFIED DRUG;

AGED; ANTIBODY SPECIFICITY; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; BRAIN INFARCTION; CONTROLLED STUDY; DIABETES MELLITUS; DIAGNOSTIC VALUE; FEMALE; HEART ATRIUM FIBRILLATION; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PROGNOSIS; RISK FACTOR;

ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, ANTIPHOSPHOLIPID; BIOLOGICAL MARKERS; CEREBRAL INFARCTION; FEMALE; HUMANS; MALE; MIDDLE AGED; PHOSPHATIDYLSERINES; PROTHROMBIN;

EID: 70349545569     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.48.2232     Document Type: Article

References (9)

1. Bajaj SP, Rapaport SI, Fierer DS, Herbst KD, Schwartz DB. A mechanism for the hypoprothrombinemia of the acquired hipoprothrombinemia-lupus anticoagulant syndrome. Blood 61: 684-692, 1983.
2. Simmelink M, Horbach D, Derksen R, et al. Complexes of antiprothrombin antibodies and prothrombin causes lupus anticoagulant activity by competing with the binding of clotting factors for catalytic phospholipids surfaces. Br J Haematol 113: 621-629, 2001.
3. Atsumi T, Ieko M, Bertolaccini ML, et al. Association of autoantibodies against the phosphatidylserine-prothrombin complex with manifestation of the antiphospholipid syndrome and with the presence of lupus anticoagulant. Arthritis Rheum 43: 1982-1993, 2000.
4. Miyakis S, Lockshin MD, Atsumi T, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 4: 295-306, 2006.
5. Ieko M, Nakabayashi T, Tarumi T, et al. Phosphatidylserine-dependent anti-prothrombin antibody as a new marker for the diagnosis of antiphospholipid syndrome. Rinsho Byori 54: 256-262, 2006 (in Japanese).
6. Matsuda J, Saitoh N, Gotoh M, Kawasugi K, Gohchi K, Tsukamoto M. Phosphatidylserine-dependent anti-prothrombin antibody is exclusive to patients with lupus anticoagulant. Br J Rhematol 35: 589-591, 1996.
7. Okuma H, Kitagawa Y, Kobori S, Sekiyama S, Takagi S. Prevalence rates of antiphospholipid antibodies in ischemic stroke patients. Intern Med 45: 1017-1018, 2006.
8. Bertolaccini ML, Atsumi T, Koike T, Hughes GR, Khanashta MA. Antithrombin antibodies detected in two different assay systems. Prevalence and clinical significance in systemic lupus erythematosus. Thromb Haemost 93: 289-297, 2005.
9. Amengual O, Atsumi T, Koike T. Specificities, properties, and clinical significance of antiphospholipid antibodies. Arthritis Rheum 48: 886-895, 2003.